Susquehanna International Group’s Ambrx Biopharma Inc AMAM Stock Holding History

Susquehanna International Group’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54,600	Closed	-$778K	–	13756
2023 Q4	$778K	Sell	54,600 -41,200	-43%	-$468K	﹤0.01%	7603
2023 Q3	$1.1M	Buy	95,800 +47,600	+99%	+$648K	﹤0.01%	6421
2023 Q2	$793K	Sell	48,200 -3,800	-7%	-$47.8K	﹤0.01%	7215
2023 Q1	$464K	Buy	52,000 +4,600	+10%	+$23.1K	﹤0.01%	8744
2022 Q4	$108K	Buy	+47,400	New	+$54.2K	﹤0.01%	10903

Susquehanna International Group's AMAM Position: Q1 2024 in Review

Susquehanna International Group sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 49,203 shares — an estimated $701K sold.

Susquehanna International Group first reported a position in AMAM in Q3 2022 and held it in 5 quarters. The position peaked at $844K in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Susquehanna International Group reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Susquehanna International Group sold 49,203 Ambrx Biopharma Inc shares in Q1 2024, an estimated $701K.
Susquehanna International Group first reported a position in Ambrx Biopharma Inc in Q3 2022 and held it in 5 quarters.
Susquehanna International Group's Ambrx Biopharma Inc position peaked at $844K in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.